NCT03354559

Brief Summary

In severe trauma patients, uncontrolled bleeding is a major cause of death, partly caused by trauma-induced coagulopathy (TIC).TIC represents a severe post-traumatic complication associated with increased transfusion requirements and worsened mortality. Fibrinolysis is a central part of the TIC process. Massive Transfusion Protocols (MTPs) were introduced as part of damage control resuscitation, with the aim to facilitate rapid blood product release and to increase adherence to hemostatic resuscitation, In 2013, the Italian Trauma Centers Network (TUN) developed a new treatment algorithm providing early coagulation support (ECS) to control coagulopathy and hemorrhage in major trauma patients with a clinically relevant bleeding risk. The protocol includes the use of fibrinogen concentrate and RBC during initial resuscitation, and the early use of viscoelastic techniques when available (thromboelastometry ROTEM® or thromboelastography TEG). The aim of this multicenter, before and after study was to assess the effects of a new ECS protocol compared to the standard MTP in terms of blood products' consumption and clinical outcome.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
235

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2011

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2014

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

November 8, 2017

Completed
20 days until next milestone

First Posted

Study publicly available on registry

November 28, 2017

Completed
Last Updated

November 28, 2017

Status Verified

November 1, 2017

Enrollment Period

4 years

First QC Date

November 8, 2017

Last Update Submit

November 24, 2017

Conditions

Keywords

coagulopathytraumableedingfibrinogentransfusion

Outcome Measures

Primary Outcomes (1)

  • Reduction of transfused units

    Amounts of transfused red blood cells, fresh frozen plasma and platelets between the two groups

    24 hours

Secondary Outcomes (2)

  • clinical outcome: the effects of the ECS protocol on length of stay

    6 months

  • clinical outcome: the effects of the ECS protocol on mortality

    24 hours-28 days

Study Arms (2)

pre-ECS group

Data collection from 01-01-2011 to 31-12-2012. Patients were treated according to a massive transfusion protocol with the following targets: fresh frozen plasma(FFP)/packed red blood cells(PRBCs) ratio ≥ 1:1.5, target platelet count \> 100.000 x 10 9/L

ECS group

Data collection from 01-01-2013 to 31-12-2014. Patients were treated according to the ECS protocol.

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All consecutive adult patients with major trauma at risk of bleeding admitted to the emergency department of two referral Trauma Centres in Rome, Italy (i.e. Fondazione Policlinico Universitario A. Gemelli and S. Camillo Hospital).

You may qualify if:

  • patients with major trauma with active bleeding or deemed at high risk of significant bleeding according to mechanism of injury;
  • patient with at least one of the following criteria were present on admission: lactate ≥ 5 mmol/L, BE ≤ - 6, or Hb ≤ 9g/dL on the blood gas analysis and SBP\<90 mmHg

You may not qualify if:

  • Patients with cardiac arrest following trauma
  • patients who died en route
  • patients who were transferred more than six hours after the trauma
  • patients or with incomplete medical reports

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hemostatic DisordersWounds and InjuriesHemorrhage

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesHemorrhagic DisordersHematologic DiseasesHemic and Lymphatic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
consultant physician; responsible coordinator on major trauma pathway

Study Record Dates

First Submitted

November 8, 2017

First Posted

November 28, 2017

Study Start

January 1, 2011

Primary Completion

December 31, 2014

Study Completion

December 31, 2014

Last Updated

November 28, 2017

Record last verified: 2017-11